ralphazard, extremely timely reminder about Bavituximab potential in hepatocellular cancer. I would expect results similar to those we will find with Bavi and irradiation therapy, and with the latter I would expect dosage levels of Bavi of approximately what is being used for HCC with sorafenib (3mg/kg.) That's a lotta Bavi.